The Immunobiology Working Party

Similar documents
Does NK cell alloreactivity prevent relapse? Yes!!! Andrea Velardi Bone Marrow Transplant Program University of Perugia

3 rd EBMT International Transplant Course

Is in vitro T-cell depletion necessary for Haploidentical TransplantationTitle of Presentation. Disclosure of Interest: Nothing to Disclose

Innovative Strategies in Pediatric Oncology: for a Proactive Surgical and Clinical Approach

Hematologic diseases in the elderly. Promoted by. Organized by Institute of Hematology L. e A. Seràgnoli University of Bologna

Current Status of Haploidentical Hematopoietic Stem Cell Transplantation

Immunotherapy in Hematological Malignancies 2018

One Day BMT Course by Thai Society of Hematology. Management of Graft Failure and Relapsed Diseases

Immunotherapy in Hematological Malignancies 2018

The question is not whether or not to deplete T-cells, but how to deplete which T-cells

Exploiting NK-cell alloreactivity in AML

4nd Patient and Family Day

Alloreattività e Tolleranza nei Trapianti di Cellule Staminali Emopoietiche Allogeniche

EBMT Society EBMT. History Organisation Studies Activity Philosophy. EBMT Website. European Group for Blood and Marrow Transplantation

Consensus Conference on Clinical Practice in Chronic GVHD Regensburg

PULMONARY HYPERTENSION. by CLINICAL CASES. Archiginnasio Palace

Immunotherapy of childhood cancer

Patronage requested A. ANICHINI (MILAN, ITALY) L. CERCHIETTI (NEW YORK, USA) M.P. COLOMBO (MILAN, ITALY) P. CORRADINI (MILAN, ITALY)

Haplo vs Cord vs URD Debate

Mayo Clinic Course on Hematology, Oncology & Blood & Marrow Transplant for NPs & PAs

PULMONARY HYPERTENSION. by CLINICAL CASES. An educational event of the University of Bologna Master Degree in Pulmonary Vascular Diseases

Haploidentical Transplantation today: and the alternatives

LIQUID BIOPSY: TRACKING CANCER

FIRST INTERNATIONAL PADUA MEETING ON SEVERE BLEEDING MANAGEMENT

November, 15th 16th 2013 N 7 CREDITI FORMATIVI ECM ISCRIZIONE GRATUITA. Venue: Villa Bardini Costa San Giorgio 2 Firenze. Con il Patrocinio di:

FLORENCE SPORT MEDICINE FLORENCE LIFESTYLE: FROM ATHLETES TO THE PATIENTS

Tregs and Tcons adoptive immunotherapy in T-cell depleted full-haplotype mismatched HSCT

International Society of Microbiota

The Days of Miracles & Wonder... and Science

Federica Galaverna, 1 Daria Pagliara, 1 Deepa Manwani, 2 Rajni Agarwal-Hashmi, 3 Melissa Aldinger, 4 Franco Locatelli 1

June 4 th - 6 th 2014 Milazzo, Italy. 3 rd Workshop on Synaptic Plasticity: from bench to bedside

7 th INTERNATIONAL CONGRESS. President: Professor P.A. Grossi, Varese

RARE ANAEMIAS 2 ND EUROPEAN SYMPOSIUM ON MARCH 2008 FIRST ANNOUNCEMENT. ABSTRACT SUBMISSION Last day of Abstract submission 15 January 2008

6 TH ESO-SIOP EUROPE MASTERCLASS IN PAEDIATRIC ONCOLOGY June 2016 Berlin, Germany. Chairs: A. Eggert, DE B. Morland, UK R.

FLORENCE SPORT MEDICINE FLORENCE LIFESTYLE: FROM ATHLETES TO THE PATIENTS

BMT Winter Workshop. 3:05-6:20 PM Workshop - 18 speakers. (Break: 4:35PM)

Sami Bahna, Shreveport, LA (USA) Daniel Ein, Washington, DC (USA) Lawrence M. DuBuske, Gardner, MA (USA)

XIII INTERNATIONAL VETERINARY ACUPUNCTURE

International Symposium on: NEW TRENDS IN DIABETES AND OBESITY TREATMENT

Lymphoma Conference. Rome, March rd POSTGRADUATE. VOI Donna Camilla Savelli Hotel. Scientific Committee: Presidents:

What s a Transplant? What s not?

FLORENCE SPORT MEDICINE FLORENCE LIFESTYLE: FROM ATHLETES TO THE PATIENTS

ASBMT Fall Clinical Education Conference

The First National Congress of the Romanian Society of Bone Marrow Transplant - Bone Marrow Transplant A Life-Saving Treatment -

Giornate Ematologiche Vicen1ne Vicenza,

PROGRAMME AND REGISTRATION

under the aegis of cover picture: Chiostro d Onore University of Milan

Cultivated anti-aspergillus T H 1 Cells. Thomas Lehrnbecher Pediatric Hematology and Oncology Frankfurt/Main, Germany

The Organizing Committee

Target audience. Chair. Xxx Xxx

Fondazione IRCCS, Istituto Nazionale dei Tumori. 2-4 March Milan, Italy

Haploidentical Donor Transplants: Outcomes and Comparison to Other. Paul V. O Donnell BSBMT Education Day London 12 October 2011

Clinical. Update in Respiratory Medicine. International Symposium on. Barcelona (Spain) February 23 rd -24 th, 2018 FINAL PROGRAMME

INTERNATIONAL MEETING SPONDYLOSIS and SPONDYLITIS

LEUKEMIAS 2017 ACUTE & CHRONIC ENCORE AT WYNN LAS VEGAS LAS VEGAS, NEVADA OCTOBER 6 7, 2017

POSTGRADUATE LEUKEMIA CONFERENCE LEUKEMIA 2018 ROME (ITALY), MAY 24-25, 2018 CME CREDITS XX. Scientific Coordinator Angelo Michele Carella

CURRENT STRATEGIES TO OPTIMALLY TREAT PATIENTS WITH DIABETES AND CVD

EBMT 2017 Satellite Symposium

21/05/2018. Continuing Education. Presentation Recording. learn.immucor.com

BOLZANO March 21-23, 2019

What s new in Blood and Marrow Transplant? Saar Gill, MD PhD Jan 22, 2016

Frankfurt, January

KIDNEY LIVER MEETS FINAL PROGRAM KIDNEY MEETS LIVER. When the excellence in renal and liver medicine come together. XXXXXXX

A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia

State of the Art Symposium

Blood and Marrow Transplant (BMT) for Sickle Cell Disease

3,4, Xiao-jun Huang 5, Fabio Ciceri 6, and Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy

SIOP. 7 TH ESO-SIOP EUROPE MASTERCLASS IN PaEDiatRic OncOlOGy June 2018 nauen Ot Groß Behnitz (Berlin area), Germany.

. TCR Alpha, Beta and CD19+ Cell Depleted Haploidentical Transplant for Primary Immunodeficiency Disorders Feb 22 nd,2018

Le infezioni fungine nel trapianto di cellule staminali emopoietiche. Claudio Viscoli Professor of Infectious Disease University of Genova, Italy

International Meeting dedicated to the memory of Raisa Gorbacheva. HEMOPOIETIC STEM CELLS TRANSPLANTATION Saint-Petersburg, September 21-22, 2007

Challenges in the Diagnosis and Management of Bleeding Disorders Hemostasis Round Round 3: Riviera Hotel, Beirut February 1, 2014

Galderma Pre-Board Slide Seminar 2009 July 17-19, 2009

options in Myeloablative HSCT


The future of HSCT. John Barrett, MD, NHBLI, NIH Bethesda MD

Ospedale Pediatrico Bambino Gesù, Rome, Italy, 2. Bellicum Pharmaceuticals Inc., Houston, United States

Acute Graft-versus-Host Disease (agvhd) Udomsak Bunworasate Chulalongkorn University

Donor Lymphocyte Infusion for Malignancies Treated with an Allogeneic Hematopoietic Stem-Cell Transplant

8 th EULAR Course on Capillaroscopy in Rheumatic Diseases

Galderma Pre-Board Slide Seminar 2010

Stem Cell Transplantation

Trends in Hematopoietic Cell Transplantation. AAMAC Patient Education Day Oct 2014

Evolving role of immunotherapy in acute myeloid leukemia

Published Ahead of Print on May 10, 2018, as doi: /haematol Copyright 2018 Ferrata Storti Foundation.

INTERNATIONAL HIP MEETING

Il Trapianto da donatore MUD. Alessandro Rambaldi

Faculty and Agenda The full list of faculty and 2-day agenda are provided below.

DFG. DFG Hinterzartener Kreis für Krebsforschung. From Molecular Mechanisms to Targeted Cancer Therapy

MD SHRM STATE CONFERENCE

Target audience. Chair. Xxx Xxx

THE NEW ERA OF PGS APPLICATION IN ART

International workshop NO-CANCER 2017 From Cancerogenesis to Therapy: new paradigms, new opportunities

6 th International Forum

EXHIBITOR AND SPONSORSHIP PROSPECTUS. HTRS 2015 Scientific Symposium April 16-18, 2015 Hilton New Orleans Riverside New Orleans, LA

13-14 October Athens, Greece

AOSpine Masters Symposium Novel and Emerging Technologies in Translational Medicine

SCIENTIFIC TIMETABLE SIOP 2015

AOSpine Advanced Seminar Intraoperative neuro-monitoring in spinal surgery; Signal interpretation and actions

MAY 24-26, 2018 ADVANCES IN REPRODUCTIVE MEDICINE: FOCUS The State of the Art 40 years after the birth of Louise Brown

Transcription:

The Immunobiology Working Party Educational Event 28-29 September 2013,, Italy Faculty of Medicine, University of Chairman: Andrea Velardi

I am happy to announce the upcoming EBMT Immunobiology Working Party (IWP) Educational Event to be held in on 28 th -29 th September 2013. The meeting focuses on immunology, immunogenetics, tolerance and graft-vs-leukemia effects in allogeneic hematopoietic transplantation and immunotherapies for leukemia and infection. I would like to thank speakers and chairpersons for making such a wonderful effort to ensure the meeting is successful and for creating such an exciting program. I am confident all the participants will enjoy the encounter and would like to thank them for their enthusiasm and interest in the topics that will be presented! Andrea Velardi EBMT-IWP Chair Saturday, 28 th September 10.50 a.m. Welcome address Andrea Velardi (IWP Chair) Antoine Toubert (IWP Secretary) Session 1: Improving GvL while attenuating GvH reactions across HLA barriers Chairs: Massimo F Martelli (), Maurizio Caniglia () 11.00 a.m. Pediatric haploidentical transplantation with TcR alpha/ beta depleted hematopoietic grafts in Tübingen Rupert Handgretinger (Tübingen) 11.20 a.m. Discussion 11.30 a.m. Pediatric haploidentical transplantation with TcR alpha/beta depleted hematopoietic grafts in Franco Locatelli () 11.50 a.m. Discussion 12.00 p.m. Haploidentical transplantation with unmanipulated G-CSF primed bone marrow and intensified immune suppression William Arcese () 12.20 p.m. Discussion 12.30 p.m. Haploidentical transplantation with unmanipulated grafts and post-transplant rapamycin or cyclophosphamide Fabio Ciceri () 12.50 p.m. Discussion 13.00 p.m. Lunch

Session 1: Improving GvL while attenuating GvH reactions across HLA barriers (cont d) 14.00 p.m. Haploidentical unmanipulated bone marrow transplantation and post-transplantation cyclophosphamide Andrea Bacigalupo, Alida Dominietto (Genoa) 14.20 p.m. Discussion 14.30 p.m. Haploidentical transplantation with TcR alpha/ beta depleted hematopoietic grafts in adults Franco Aversa (Parma) 14.50 p.m. Discussion 15.00 p.m. Transferring natural and adaptive immunity to improve outcomes of haploidentical hematopoietic transplants Andrea Velardi () 15.20 p.m. Discussion 15.30 p.m. Coffee Break Session 2: Alloreactivity and immune regulation Chair: Antoine Toubert (Paris), Andrea Velardi () 15.50 p.m. Immune pathogenesis of GvHD Ernst Holler (Regensburg) 16.10 p.m. Discussion 16.20 p.m. Therapeutic immune regulation with mesenchymal stem cells Willem Fibbe (Leyden) 16.40 p.m. Discussion 16.50 p.m. Immune regulation with T regs: improving selection and expansion Mauro Di Ianni (L Aquila) 17.00 p.m. Discussion 17.05 a.m. Epigenetic measurement of T regs in transplantation, autoimmunity and cancer immunotherapy Sven Olek (Berlin) 17.15 p.m. Discussion 17.20 a.m. Role of thymic function in transplantation outcomes Antoine Toubert (Paris) 17.40 p.m. Discussion 17.50 p.m. Boosting thymic function with alloreactive NK cells Loredana Ruggeri () 18.10 p.m. Discussion Sunday, 29 th September Session 3: Immunotherapy of infection Chairs: Hermann Einsele (Würzburg), Luigina Romani () 08.30 a.m. Strategies for rebuilding viral and fungalspecific T cell immunity Hermann Einsele (Würzburg) 8.50 a.m. Discussion 09.00 a.m. The gut microbiota in BMT- focus on fungal pathogenesis and therapeutics Luigina Romani () 09.20 a.m. Discussion 09.30 a.m. Immunogenetics of susceptibility to invasive fungal infections Agostino Carvalho () 09.45 a.m. Discussion 09.50 a.m. Coffee Break

Session 4: Immunotherapy of leukemia Chairs: Brunangelo Falini (), Robin Foa () 10.10 a.m. Blinatunomab for the treatment of lymphoproliferative disorders Hermann Einsele (Würzburg) 10.30 a.m. Discussion 10.40 a.m. Immunotherapy of leukemia with TCR transduced T cells Chiara Bonini () 11.00 a.m. Discussion 11.10 a.m. Immunotherapy of leukemia with chimeric antigen receptor-redirected T cells Attilio Bondanza () 11.30 a.m. Discussion 11.40 a.m. Quantifying graft-versus-leukemia: an analysis of 50 000 transplants over one decade Martin Stern (Basel) 12.00 a.m. Discussion 12.05 a.m. Immunotherapy of Acute Myeloid Leukemia in the elderly with alloreactive NK cells Antonio Curti (Bologna) 12.25 a.m. Discussion Faculty William Arcese Franco Aversa Andrea Bacigalupo Attilio Bondanza Chiara Bonini Maurizio Caniglia Agostinho Carvalho Fabio Ciceri Antonio Curti Mauro Di Ianni Alida Dominietto Hermann Einsele Brunangelo Falini Parma Genoa Bologna L Aquila Genova Würzburg General Information Congress Venue University of - Faculty of Medicine, Bulding B, Hall 8 Sant Andrea delle Fratte - - Italy (see attached map). Willem Fibbe Robin Foa Rupert Handgretinger Ernst Holler Franco Locatelli Massimo F. Martelli Sven Olek Luigina Romani Loredana Ruggeri Martin Stern Antoine Toubert Andrea Velardi Free Registration On line registration and hotel booking: http://95.228.73.194/cmsweb/login.asp?idcommessa=c13015&lang=it CME Accreditation The event has been accredited for 120 people. Accredited professions BIOLOGISTS PHISICIANS Disciplines: Hematology, Allergology and Clinical Immunology, Microbiology and Virology, Oncology, Infectious Diseases, Clinical Pathology, Transfusion Medicine. Leyden Tübingen Regensburg Berlin Basel Paris Credits assigned: 7,5 The issue of CME certificate is subject to: - having taken part in the whole event; - having passed the learning questionnaire; - having provided all the requested data. The certificate will be sent after the congress.

FROM FLORENCE EXIT: MADONNA ALTA FROM ROME or PERUGIA City Center From the south Motorway A1 Exit at Orte Continue towards and then take direction -Firenze (A1). Exit at Madonna Alta. From the city center Follow the signs to Firenze (A1). Once on the highway exit at Madonna Alta From the north Motorway A1 Exit at Val di Chiana Follow the signs to, pass Trasimeno Lake and continue to. Exit at Madonna Alta GPS Coordinates 43 4 40.00 N 12 21 17.00 E Silvestrini Hospital Faculty of Medicine Parking Area Congress Venue With the unrestricted contribution of ORGANIZING AGENCY C.S.C. S.r.l. Provider ECM accreditato al Ministero della Salute Rif. 505 Via L.S. Gualtieri, 11-06123 - Tel 075 5730617 - Fax 075 5730619 Project Leader: Emanuela Fuso emanuela@csccongressi.it from Monday to Friday 9.00 a.m. to 6.00 p.m. www.csccongressi.it